Quantcast

Latest rheumatoid arthritis Stories

2014-06-03 12:39:19

Leveraging Nurse Support Could Boost Engagement with Rheumatoid Arthritis Brands, According to Findings in New Manhattan Research Analysis from Decision Resources Group BURLINGTON, Mass., June 3, 2014 /PRNewswire/ -- Manhattan Research's new Digital Competitive Landscape analysis finds that many rheumatoid arthritis (RA) brands are overlooking valuable ways to reach patients and physicians through digital channels and support their evolving needs. Each opportunity represents a risk in a...

2014-05-29 16:26:10

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test. This follows the very recent publication of a study...

2014-05-28 23:01:14

Colarasis, Inc. now offers Roman’s Pain Rub, a skin balm formulated to relieve pain. Houston, TX (PRWEB) May 28, 2014 In business since May 2010, Colarasis, Inc. is now offering a pain relief rub proven to help the millions of people who suffer from arthritis pain. Colarasis, Inc. of Houston, TX recently formulated Roman’s Pain Rub, an analgesic skin balm that consists of rich and pure emollients, lubricants and penetrating agents. It acts as a numbing sensation which generates to...

2014-05-19 16:22:29

Early diagnosis and treatment can help you maintain an active lifestyle ROSEMONT, Ill., May 19, 2014 /PRNewswire-USNewswire/ -- Suffering with pain or stiffness in your feet and ankles? It could be arthritis. More than 52 million Americans have the condition, which destroys the normal workings of a joint. Arthritis most commonly affects the knees, hands, hips and spine, all of which impact quality of life in some way. But when arthritis affects the feet and ankles, mobility can be...

2014-05-15 08:31:49

Biologic with unique therapeutic approach for OA, which affects over 80 million worldwide CLEVELAND, May 15, 2014 /PRNewswire-USNewswire/ -- NovelMed Therapeutics announced today positive data using its novel, humanized monoclonal antibody in two well-established models of osteoarthritis (OA), characterized by osteophyte formation and cartilage loss. Approximately one in ten people worldwide are affected by OA, with the total number of afflicted patients expected to increase from 75...

2014-05-13 15:45:49

Walter & Eliza Hall Institute of Medical Research A team of Melbourne researchers has shown a recently discovered type of cell death called necroptosis could be the underlying cause of inflammatory disease. The research team discovered that a previously identified molecule involved in necroptosis, called RIPK1, was essential for survival by preventing uncontrolled inflammation. This finding could lead to future treatments for inflammatory diseases including Crohn’s disease,...

2014-05-13 08:31:25

Consensus Statement Supports Adoption of Psoriasis Resolution by the World Health Organization (WHO) at Upcoming 67th World Health Assembly PORTLAND, Ore., May 13, 2014 /PRNewswire-USNewswire/ -- The International Federation of Psoriasis Associations (IFPA), European Federation of Psoriasis Associations (EUROPSO), National Psoriasis Foundation (NPF) and The Arthritis Society today issued a joint consensus statement to provide a framework addressing the unmet needs faced by the over 125...

2014-05-12 23:11:15

polyDNA’s newest survey for the month of May discovered that 36% of respondents with arthritis wanted to know if EBV is the cause of their disease. polyDNA reviews the literature on this topic and recommends Gene-Eden-VIR and Novirin against EBV, which is linked to arthritis. Rochester, NY (PRWEB) May 12, 2014 polyDNA’s latest survey revealed that 36% of respondents with arthritis wanted to know if EBV is the cause of their disease. One study found that “In latent and replicating...

2014-05-05 00:21:27

COVA322 is First of Covagen's Bispecific FynomAbs to Enter Clinical Trials ZURICH-SCHLIEREN, Switzerland, May 5, 2014 /PRNewswire/ -- Covagen today announced it has initiated a Phase Ib/IIa study with COVA322, a bispecific TNF/IL-17A inhibitor. COVA322 is Covagen's lead bispecific FynomAb® developed for treatment of patients with rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases. The trial will enroll 39 patients with psoriasis and evaluate safety as well as...

2014-05-01 08:31:52

VANCOUVER, May 1, 2014 /CNW/ - Successful organizations are paying more attention to the needs of employees living with arthritis, underlining the significant role 4.6 million Canadians living with arthritis have in the work force and economy. Today at the 2014 Canadian Life and Health Insurance of Canada Annual Claims Conference in Quebec City, Arthritis Consumer Experts (ACE) announced a nationwide search for best arthritis strategies and practices in the Canadian workplace as...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related